000 01462 a2200433 4500
005 20250518052144.0
264 0 _c20210621
008 202106s 0 0 eng d
022 _a1874-4702
024 7 _a10.2174/1874467212666190920144115
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFu, Ailing
245 0 0 _aMitotherapy as a Novel Therapeutic Strategy for Mitochondrial Diseases.
_h[electronic resource]
260 _bCurrent molecular pharmacology
_c2020
300 _a41-49 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aCell Survival
650 0 4 _aCell-Derived Microparticles
650 0 4 _aCells, Cultured
650 0 4 _aCoronary Vessels
650 0 4 _aEnergy Metabolism
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInjections, Intra-Arterial
650 0 4 _aMammals
650 0 4 _aMice
650 0 4 _aMitochondria
_xphysiology
650 0 4 _aMitochondrial Diseases
_xtherapy
650 0 4 _aMyocardial Ischemia
_xtherapy
650 0 4 _aNanotubes
650 0 4 _aNeoplasms
_xtherapy
650 0 4 _aOxygen Consumption
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aSpecies Specificity
773 0 _tCurrent molecular pharmacology
_gvol. 13
_gno. 1
_gp. 41-49
856 4 0 _uhttps://doi.org/10.2174/1874467212666190920144115
_zAvailable from publisher's website
999 _c29939618
_d29939618